Dermatopharmacologists develop and test medications for skin, hair, and nail conditions. They research, formulate, and evaluate treatments for disorders such as acne, eczema, psoriasis, and skin infections. Their work involves understanding how different drugs interact with the skin and improving their absorption, effectiveness, and safety. Collaborating with dermatologists, pharmacologists, and researchers, they create topical creams, oral medications, and injectable treatments to manage and cure various skin conditions. Their work includes evaluating topical and systemic medications for conditions such as acne, eczema, psoriasis, and skin infections. By assessing drug formulations, absorption rates, and safety profiles, they help optimize treatments for maximum effectiveness while minimizing side effects. Innovations in nanotechnology, biotechnology, and transdermal drug delivery systems enhance targeted therapies for various skin disorders.
Dermatopharmacologists contribute to advancements in skincare and cosmetic dermatology by creating innovative treatments for anti-aging, hyperpigmentation, and scar reduction. They conduct clinical trials to assess the efficacy and safety of new dermatological drugs before they become widely available. Their research enhances existing treatments and helps develop targeted therapies for complex skin diseases, including autoimmune and genetic disorders. By combining knowledge in pharmacology and dermatology, dermatopharmacologists play a key role in ensuring patients have access to effective and safe treatments for both medical and cosmetic skin concerns.
Title : Paraneoplastic autoimmune multiorgan syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States
Title : Modern non-invasive methods for in vivo assessment of skin
Georgios N Stamatas, SGS, France
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The next generation of threads: Lifting, volumization, and biostimulation in one powerful triple action
George Sulamanidze, Plastic Surgeon at Clinic of Plastic and Aesthetic Surgery and Cosmetology TOTALCharm, Georgia
Title : Lymphoproliferative diseases in the practice of a dermatologist
Irina Sergeeva, Novosibirsk State University, Russian Federation
Title : Comparative efficacy of omalizumab and dupilumab in children with Chronic Spontaneous Urticaria (CSU): A retrospective cohort analysis
Molynna Nguyen, University of Toledo, United States
Title : "Mirror mirror on the skin” — A low-cost community strategy to reduce melanoma disparities in Washington, D.C.
Kayla Sampson, Georgetown University School of Medicine, United States
Title : Vitiligo: Not just an aesthetic disorder
Mateja Starbek Zorko, University Medical centre Ljubljana, Slovenia
Title : Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure the national biosafety: Advanced skincare solutions in individualized cosmetology, reconstructive plastic surgery and the modern beauty
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Keratinocyte apoptosis by caspase – 3 Immunostaining in histopathology as marker of activity as well as correlation with dermoscopy findings in Cutaneous Lupus Erythematosus (CLE) in skin of color: An observational study.
Subhojit Ray, All India Institute of Medical Sciences, India